“The Delhi-based International Centre for Genetic Engineering and Biotechnology (ICGEB) and the Lala Ram Sarup Institute of Tuberculosis and Respiratory Diseases, collaborated with the National University of Singapore to develop” a urine test that “offers a less invasive diagnostic method for” tuberculosis (TB), SciDev reports. “Drug-resistant cases need an expensive, sophisticated test that takes two weeks of culturing blood samples to detect the bacterium,” but developing countries, which “account for 95 percent of new infections and 98 percent of deaths … prefer a simple test requiring minimum resources and trained personnel, and one that gives quick and easily interpreted results, the Delhi scientists observed,” according to the news agency (Padma, 8/23).
The Global Fund to Fight AIDS, Tuberculosis and Malaria, which “froze disbursements of its AIDS grant to China in November and all other grants in May over suspected misuse of the money and the government’s reluctance to involve community groups, … said Tuesday that it was lifting the freeze on financing to ensure that AIDS work in China continued while it worked with government officials, representatives from United Nations agencies and private groups to resolve the dispute,” the Associated Press reports.
Research of the common tuberculosis (TB) drug pyrazinamide, which is used in combination with other medications to treat the disease in a six-month regimen, “has now revealed that the drug does kill the latent form of the microbe, which does not cause observable symptoms,” VOA News reports.
As countries increase the use of the GeneXpert test, a two-hour molecular TB test released in 2010, “enabl[ing] them to diagnose more patients with drug-resistant tuberculosis (DR-TB), a worldwide shortage of the drugs to treat these patients is likely, Medecins Sans Frontieres (MSF) warns,” according to PlusNews.
Bayer Healthcare announced on MondayÂ it “has agreed to support the World Health Organization (WHO) and the Stop TB Partnership in the fight against multidrug-resistant tuberculosis (MDR-TB) by making 620,000 tablets of the antibiotic moxifloxacin available to WHO,” according to a Bayer press release.Â The WHO will provide the antibiotics to China’s…
A guest post in PLoS Medicine’s “Speaking of Medicine” blog, written by tuberculosis (TB) researchers Madhukar Pai of McGill University, David Dowdy of the Johns Hopkins Bloomberg School of Public Health, and Karen Steingart of the University of Washington School of Public Health, examines the medical, public health and economic…
CDC Director Thomas Frieden, who currently is visiting India and who previously worked with the Indian government assisting in tuberculosis (TB) control, praised the country’s “progress in controlling tuberculosis and tobacco use” on Monday during a speech to health practitioners and policymakers, according to the Wall Street Journal’s “India Real Time” blog. Frieden also noted “India’s strides in the past decade on â€¦ polio control and HIV/AIDS prevention,” the blog reports.
U.S. Delegation in South Africa To Renew Bilateral Relationship, Create Sustainable Partnerships in Health
This post on the Center for Strategic and International Studies (CSIS)’s Commission on Smart Global Health Policy blog examines tuberculosis (TB) in South Africa, “which has the highest tuberculosis infection rate per population and accounts for 5 percentÂ of the global TB burden.” The post isÂ part of a seriesÂ to be posted…
The June/July issue of USAID’s Frontlines focuses on climate change, including an article on how Kenyan farmers are adapting to environmental changes. The issue also includes articles on how the search for an HIV vaccine has boosted African research and on the introduction of the GeneXpert tuberculosis test in Central…
The WHO “called on Wednesday for an immediate halt to the use of blood tests to detect active tuberculosis [TB], saying they were faulty and leave millions of people at risk,” Reuters reports.